Clinical Trial

The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Ultrasound Guided Peripheral Nerve Blocks as a Solo Anesthetic Technique in High Risk Patients Undergoing Unilateral Above Knee Amputation .

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to compare the analgesic efficacy and safety of dexmedetomidine versus fentanyl as adjuvants to bupivacaine in ultrasound-guided combined supra-inguinal fascia iliaca and proximal sciatic nerve blocks used as a solo anesthetic technique in high-risk patients undergoing unilateral above knee amputation.
Trial Details
NCT Number NCT07640516
Lead Sponsor Kasr El Aini Hospital
Conditions Analgesia Assessment, Above Knee Amputation, Fentanyl vs Dexmedetomidine
Enrollment 64 participants
Start Date 2026-07-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10